JP2010524894A5 - - Google Patents

Download PDF

Info

Publication number
JP2010524894A5
JP2010524894A5 JP2010503511A JP2010503511A JP2010524894A5 JP 2010524894 A5 JP2010524894 A5 JP 2010524894A5 JP 2010503511 A JP2010503511 A JP 2010503511A JP 2010503511 A JP2010503511 A JP 2010503511A JP 2010524894 A5 JP2010524894 A5 JP 2010524894A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
optionally substituted
carbocyclyl
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010503511A
Other languages
English (en)
Japanese (ja)
Other versions
JP5675341B2 (ja
JP2010524894A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/054711 external-priority patent/WO2008128982A1/en
Publication of JP2010524894A publication Critical patent/JP2010524894A/ja
Publication of JP2010524894A5 publication Critical patent/JP2010524894A5/ja
Application granted granted Critical
Publication of JP5675341B2 publication Critical patent/JP5675341B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010503511A 2007-04-18 2008-04-18 グルタミニルシクラーゼ阻害剤としてのチオキソキナゾリノン誘導体 Expired - Fee Related JP5675341B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91254007P 2007-04-18 2007-04-18
US60/912,540 2007-04-18
PCT/EP2008/054711 WO2008128982A1 (en) 2007-04-18 2008-04-18 Thioxoquinazolinone derivatives as glutaminyl cyclase inhibitors

Publications (3)

Publication Number Publication Date
JP2010524894A JP2010524894A (ja) 2010-07-22
JP2010524894A5 true JP2010524894A5 (enExample) 2011-09-08
JP5675341B2 JP5675341B2 (ja) 2015-02-25

Family

ID=39684456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010503511A Expired - Fee Related JP5675341B2 (ja) 2007-04-18 2008-04-18 グルタミニルシクラーゼ阻害剤としてのチオキソキナゾリノン誘導体

Country Status (6)

Country Link
US (1) US9034907B2 (enExample)
EP (1) EP2160389B1 (enExample)
JP (1) JP5675341B2 (enExample)
DK (1) DK2160389T3 (enExample)
ES (1) ES2478673T3 (enExample)
WO (1) WO2008128982A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732162B2 (en) * 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
JP5676249B2 (ja) * 2007-04-20 2015-02-25 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのアミノピリジン誘導体
AU2008297070A1 (en) * 2007-09-12 2009-03-19 Probiodrug Ag Transgenic mice
NZ586665A (en) * 2008-01-14 2011-12-22 Probiodrug Ag MOUSE MODELS CARRYING A KNOCK-OUT MUTATION OF THE GLUTAMINYL CYCLASE GENE (Qpct)
NZ590563A (en) 2008-07-21 2012-06-29 Probiodrug Ag Diagnostic antibody assay
EP2413696A4 (en) * 2009-04-03 2012-10-24 Sinai School Medicine COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
BR112012008346B1 (pt) 2009-09-11 2021-12-21 Vivoryon Therapeutics N.V. Derivados heterocíclicos, seu processo de preparação, e composição farmacêutica
US20110152341A1 (en) 2009-12-22 2011-06-23 Probiodrug Ag Cleavage of b-amyloid precursor protein
CA2789091A1 (en) 2010-02-18 2011-08-25 Probiodrug Ag Methods of diagnosing inflammatory diseases by determining pyroglutamate-modified mcp-1 and screening methods for inhibitors of glutaminyl cyclase
EP2886120B1 (en) * 2010-10-29 2019-06-19 Emory University Quinazoline derivatives, compositions and uses related thereto
AU2012228236B2 (en) 2011-03-16 2016-10-27 Vivoryon Therapeutics N.V. Diagnostic antibody assay
WO2013181135A1 (en) * 2012-05-31 2013-12-05 Emory University Quinazoline derivatives, compositions, and uses related thereto
JP2018501482A (ja) 2014-12-19 2018-01-18 プロビオドルグ エージー pGlu−Abetaペプチドの検出のための新規の方法
PL3386591T3 (pl) 2015-12-09 2021-02-22 Novartis Ag Heteroaromatyczne modulatory receptorów nmda i ich zastosowania
ES2950348T3 (es) * 2015-12-09 2023-10-09 Novartis Ag Moduladores de receptores NMDA de tienopirimidinona y usos de los mismos
EP3558318B1 (en) 2016-12-22 2023-12-20 Novartis AG Nmda receptor modulators and uses thereof
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
EP3521308B1 (en) 2018-01-31 2024-03-13 Vivoryon Therapeutics N.V. Humanized and de-immunized antibodies
RS64359B1 (sr) 2018-08-03 2023-08-31 Novartis Ag Heteroaromatični modulatori nmda receptora i njihove upotrebe

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293500A1 (en) 1987-06-01 1988-12-07 American Cyanamid Company 3-heteroalkyl-2,4.quinzaoline-diones
US4684654A (en) 1985-08-14 1987-08-04 American Cyanamid Company 3-heteroalkyl-2,4-quinzaolinediones
US6948038B2 (en) * 2001-07-24 2005-09-20 Microsoft Corporation System and method for backing up and restoring data
AU2002352444A1 (en) 2001-12-20 2003-07-09 Celltech R And D Limited Quinazolinedione derivatives
ATE462432T1 (de) 2003-05-05 2010-04-15 Probiodrug Ag Glutaminylcyclase-hemmer
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
EP1961416B1 (en) 2003-05-05 2013-01-23 Probiodrug AG Use of inhibitors of glutaminyl cyclase for treating psoriasis, rheumatoid arthritis or atherosclerosis.
US8338120B2 (en) 2003-05-05 2012-12-25 Probiodrug Ag Method of treating inflammation with glutaminyl cyclase inhibitors
KR20120007079A (ko) 2003-10-15 2012-01-19 프로비오드룩 아게 글루타미닐 및 글루타메이트 사이클라제 이펙터의 용도
JP2007509898A (ja) 2003-11-03 2007-04-19 プロビオドルグ エージー 神経障害治療に有用な組合せ
US20050171112A1 (en) 2003-11-03 2005-08-04 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
US7667044B2 (en) 2003-11-03 2010-02-23 Probiodrug Ag Compounds for the treatment of neurological disorders
KR101099206B1 (ko) 2004-02-05 2011-12-27 프로비오드룩 아게 신규한 글루타미닐 시클라제 저해제
NZ575727A (en) 2006-09-21 2011-12-22 Probiodrug Ag Novel genes related to glutaminyl cyclase
EP2086960B1 (en) 2006-11-09 2014-03-05 Probiodrug AG Novel inhibitors of glutaminyl cyclase
US8420684B2 (en) 2006-11-09 2013-04-16 Probiodrug Ag Inhibitors of glutaminyl cyclase
EP2091948B1 (en) 2006-11-30 2012-04-18 Probiodrug AG Novel inhibitors of glutaminyl cyclase
EP2121944B1 (en) 2007-01-19 2011-08-24 Probiodrug AG In vivo screening models for treatment of alzheimer's disease and other qpct-related disorders
JP5612860B2 (ja) 2007-03-09 2014-10-22 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのイミダゾ[1,5−a]ピリジン誘導体

Similar Documents

Publication Publication Date Title
JP2010524894A5 (enExample)
HRP20191102T1 (hr) Sintetski međuprodukti za pripravu konjugata oligosaharid-protein
JP2013508347A5 (enExample)
HUE042847T2 (hu) A 44 xiloglukanáz család egyik variánsát tartalmazó felületaktív készítmény
EP2181399A4 (en) COMPOSITE STUFFED FLOWS
EP2213856A4 (en) AUSPUFFROHR
JP2010512298A5 (enExample)
EP2215068A4 (en) ANTIDIABETIC TRICYCLIC COMPOUNDS
DK3061467T3 (da) Sårforbinding med en bakterieadsorberende sammensætning
BRPI0922904A2 (pt) "compostos"
SE0601145L (sv) Vakuumöppningar av höghastighetstyp
BRPI0923786A2 (pt) compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos
EP2003132A4 (en) HETERO COMPOUND
JP2010504301A5 (enExample)
JP2015537008A5 (enExample)
JP2011510079A5 (enExample)
EP2117306A4 (en) NEUROGENIC COMPOUNDS
DK1776090T3 (da) Stabiliseret prostaglandinsammensætning
JP2011037885A5 (enExample)
DE502005005800D1 (de) Selbsteinstellendes Gleitstück für Teleskopkranausleger
FI20075529A0 (fi) Nostokoukku
DOP2011000154A (es) 3-aminociclopentancarboxamidas
JP2013512203A5 (enExample)
EP1759410A4 (en) Organotinic precursor compositions
ITTO20080025A1 (it) Attrezzatura per l'esecuzione di fori secanti.